223 related articles for article (PubMed ID: 19027812)
1. Whole tumor cell vaccine with irradiated S180 cells as adjuvant.
Li J; King AV; Stickel SL; Burgin KE; Zhang X; Wagner TE; Wei Y
Vaccine; 2009 Jan; 27(4):558-64. PubMed ID: 19027812
[TBL] [Abstract][Full Text] [Related]
2. Comparative studies of a retrovirus versus a poxvirus vector in whole tumor-cell vaccines.
Hodge JW; Schlom J
Cancer Res; 1999 Oct; 59(20):5106-11. PubMed ID: 10537283
[TBL] [Abstract][Full Text] [Related]
3. The complete preventive effect of homologous tumor vaccines--based on a 5-year experimental study in mice.
Tong X; Wang L; Liu Y; Qi Y; Qin Y; Xu Y; Tong T
Biomed Pharmacother; 2010 Nov; 64(9):605-8. PubMed ID: 20961730
[TBL] [Abstract][Full Text] [Related]
4. [Experimental studies on anti-tumor effects of BLC-modified tumor cell vaccine combined with cisplatin].
Zou CH; Tian L; Wei YQ; Zhao X; Kan B; Yang JL; Mao YQ; Wen YJ; Li J; Deng HX
Ai Zheng; 2004 Jan; 23(1):1-7. PubMed ID: 14720366
[TBL] [Abstract][Full Text] [Related]
5. Enhancement of anti-tumor immunity by high levels of Th1 and Th17 with a combination of dendritic cell fusion hybrids and regulatory T cell depletion in pancreatic cancer.
Yamamoto M; Kamigaki T; Yamashita K; Hori Y; Hasegawa H; Kuroda D; Moriyama H; Nagata M; Ku Y; Kuroda Y
Oncol Rep; 2009 Aug; 22(2):337-43. PubMed ID: 19578774
[TBL] [Abstract][Full Text] [Related]
6. DC therapy induces long-term NK reactivity to tumors via host DC.
Shimizu K; Fujii S
Eur J Immunol; 2009 Feb; 39(2):457-68. PubMed ID: 19180466
[TBL] [Abstract][Full Text] [Related]
7. Antitumor efficacy of DNA vaccination to the epigenetically acting tumor promoting transcription factor BORIS and CD80 molecular adjuvant.
Loukinov D; Ghochikyan A; Mkrtichyan M; Ichim TE; Lobanenkov VV; Cribbs DH; Agadjanyan MG
J Cell Biochem; 2006 Aug; 98(5):1037-43. PubMed ID: 16741971
[TBL] [Abstract][Full Text] [Related]
8. Whole cell ELISA for measuring anti-tumour effects of immunotherapies in a mouse tumour model of ALCL.
Carstens M; Bittner C; Krokowski M; Hadlak M; Feller AC; Merz H
In Vivo; 2003; 17(4):359-63. PubMed ID: 12929591
[TBL] [Abstract][Full Text] [Related]
9. Allogeneic melanoma vaccine expressing alphaGal epitopes induces antitumor immunity to autologous antigens in mice without signs of toxicity.
Rossi GR; Mautino MR; Awwad DZ; Husske K; Lejukole H; Koenigsfeld M; Ramsey WJ; Vahanian N; Link CJ
J Immunother; 2008; 31(6):545-54. PubMed ID: 18528300
[TBL] [Abstract][Full Text] [Related]
10. Irradiated CIITA-positive mammary adenocarcinoma cells act as a potent anti-tumor-preventive vaccine by inducing tumor-specific CD4+ T cell priming and CD8+ T cell effector functions.
Mortara L; Frangione V; Castellani P; De Lerma Barbaro A; Accolla RS
Int Immunol; 2009 Jun; 21(6):655-65. PubMed ID: 19395374
[TBL] [Abstract][Full Text] [Related]
11. Experimental study of specific immunotherapy induced by H22 autologous tumor as whole tumor cell vaccine.
Yang W; Guo C; Liu QG; Pan C
Biomed Pharmacother; 2009 Jul; 63(6):404-8. PubMed ID: 18849136
[TBL] [Abstract][Full Text] [Related]
12. Antitumor IgE adjuvanticity: key role of Fc epsilon RI.
Nigro EA; Brini AT; Soprana E; Ambrosi A; Dombrowicz D; Siccardi AG; Vangelista L
J Immunol; 2009 Oct; 183(7):4530-6. PubMed ID: 19748979
[TBL] [Abstract][Full Text] [Related]
13. Vaccination with IFN-inducible T cell alpha chemoattractant (ITAC) gene-modified tumor cell attenuates disseminated metastases of circulating tumor cells.
Yang X; Chu Y; Wang Y; Guo Q; Xiong S
Vaccine; 2006 Apr; 24(15):2966-74. PubMed ID: 16503368
[TBL] [Abstract][Full Text] [Related]
14. Immunotherapy of hepatocellular carcinoma with a vaccine based on xenogeneic homologous alpha fetoprotein in mice.
Zhang W; Liu J; Wu Y; Xiao F; Wang Y; Wang R; Yang H; Wang G; Yang J; Deng H; Li J; Wen Y; Wei Y
Biochem Biophys Res Commun; 2008 Nov; 376(1):10-4. PubMed ID: 18725206
[TBL] [Abstract][Full Text] [Related]
15. Antitumor immunity by a dendritic cell vaccine encoding secondary lymphoid chemokine and tumor lysate on murine prostate cancer.
Lu J; Zhang Q; Liang CM; Xia SJ; Zhong CP; Wang DW
Asian J Androl; 2008 Nov; 10(6):883-9. PubMed ID: 18958352
[TBL] [Abstract][Full Text] [Related]
16. An oral TLR7 agonist is a potent adjuvant of DNA vaccination in transgenic mouse tumor models.
Dharmapuri S; Aurisicchio L; Neuner P; Verdirame M; Ciliberto G; La Monica N
Cancer Gene Ther; 2009 May; 16(5):462-72. PubMed ID: 18989354
[TBL] [Abstract][Full Text] [Related]
17. Improved efficacy of DNA vaccination against prostate carcinoma by boosting with recombinant protein vaccine and by introduction of a novel adjuvant epitope.
Lu Y; Ouyang K; Fang J; Zhang H; Wu G; Ma Y; Zhang Y; Hu X; Jin L; Cao R; Fan H; Li T; Liu J
Vaccine; 2009 Aug; 27(39):5411-8. PubMed ID: 19616501
[TBL] [Abstract][Full Text] [Related]
18. Sustained and NK/CD4+ T cell-dependent efficient prevention of lung metastasis induced by dendritic cells harboring recombinant Sendai virus.
Komaru A; Ueda Y; Furuya A; Tanaka S; Yoshida K; Kato T; Kinoh H; Harada Y; Suzuki H; Inoue M; Hasegawa M; Ichikawa T; Yonemitsu Y
J Immunol; 2009 Oct; 183(7):4211-9. PubMed ID: 19734206
[TBL] [Abstract][Full Text] [Related]
19. Immunity against breast cancer by TERT DNA vaccine primed with chemokine CCL21.
Yamano T; Kaneda Y; Hiramatsu SH; Huang S; Tran AN; Giuliano AE; Hoon DS
Cancer Gene Ther; 2007 May; 14(5):451-9. PubMed ID: 17318199
[TBL] [Abstract][Full Text] [Related]
20. Delivery of whole tumor lysate into dendritic cells for cancer vaccination.
Liu LN; Shivakumar R; Allen C; Fratantoni JC
Methods Mol Biol; 2008; 423():139-53. PubMed ID: 18370195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]